mesa20160601_8k.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549   

 

Form 8-K

 


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

 

JUNE 2, 2016
Date of Report (Date of earliest event Reported)

 

MESA LABORATORIES, INC.
(Exact Name of registrant as Specified in its Charter)

 

Commission File Number: 0-11740

 

COLORADO 
(State or other Jurisdiction of
Incorporation or Organization)

 

84-0872291
(I.R.S. Employer
Identification No.)

 

 

12100 WEST SIXTH AVENUE, LAKEWOOD, COLORADO 
(Address of Principal Executive Offices)

 

  80228
(Zip Code)

 

Issuer’s telephone number, including area code: (303) 987-8000

 

Not Applicable.
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

|_|

  

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

|_|

  

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

|_|

  

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

|_|

  

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 
 
 

 

ITEM 2.02

RESULTS OF OPERATIONS AND FINANCIAL CONDITION

 

On June 2, 2016, Mesa Laboratories, Inc. issued a press release relating to its results for the three months and year ended March 31, 2016. A copy of the press release is furnished herewith as Exhibit 99.1.

 

The information furnished in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liabilities of that section, and shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended.

 

ITEM 9.01

FINANCIAL STATEMENTS AND EXHIBITS

 

(d)

Exhibits:

   
 

99.1      Press release dated June 2, 2016.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

DATE: June 2, 2016 

 

Mesa Laboratories, Inc.

 

 

(Registrant)

 

 

 

 

 

 

 

BY: 

/s/ John J. Sullivan  

 

 

John J. Sullivan

 

 

President and Chief Executive Officer